The critical priority pathogens, such as gram-negative bacteria resistant to last-resort antibiotics, and Mycobacterium tuberculosis resistant to the antibiotic rifampicin, present major global threats due to their high burden, and ability to resist treatment and spread resistance to other bacteria. Gram-negative bacteria have built-in abilities to find new ways to resist treatment and can pass along genetic material that allows other bacteria to become drug-resistant as well. In the first type of mechanism, the ion channel is part of the same protein complex as the receptor, and no biochemical intermediates are involved.
The UNGASS marked a shift in the overall drug policy discourse to highlight the public health and human rights dimensions of the world drug problem and to achieve a better balance between supply reduction and public health measures. Drugs produce harmful as well as beneficial effects, and decisions about when and how to use them therapeutically always involve the balancing of benefits and risks. Drugs approved for human use are divided into those available only with a prescription and those that can be bought freely over the counter.
Latest lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN) are also included. In April 2016, the thirtieth Special Session of the UN General Assembly (UNGASS) reviewed the progress in the implementation of the 2009 Political Declaration and Plan of Action on International Cooperation Towards an Integrated and Balanced Strategy to Counter the World Drug Problem and assessed the achievements and challenges. In resolution S-30/1, the General Assembly adopted the outcome document of the special session on the world drug problem entitled “Our joint commitment to effectively addressing and countering the world drug problem”.
A drug with the affinity to bind to a receptor but without the efficacy to elicit a response is an antagonist. Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Millennium Development Goal 8E aims for affordable access to essential medicines.Essential medicines, as defined by WHO, are those that “satisfy…
A number of therapeutic proteins, including certain antibodies, have been developed through genetic engineering. Since 1977, WHO has maintained a list of essentialmedicines as a means to promote health equity around the world. This list beganwith 208 identified medicines and has grown to include 460 differentpharmaceuticals. Although it was not designed as a global standard, the listnow acts as a guide for the procurement and supply of medicines at the nationaland local level. Differences in efficacy determine whether a drug that binds to a receptor is classified as an agonist or as an antagonist. A drug whose efficacy and affinity are sufficient for it to be able to bind to a receptor and affect cell function is an agonist.
In the choice of treatment, WHO recommends OAMT to be used for most patients as the intervention with strongest evidence of effectiveness for variety of outcomes. These include reduction in non-medical opioid use, mortality and morbidity (including due to opioid overdose, HIV and viral hepatitis), lowering risk of crime and incarceration, better retention in treatment, quality of life and overall wellbeing. In the guidelines on community management of opioid overdose, WHO recommends that people who are likely to witness an opioid overdose, including people who use opioids, and their family and friends should be given access to naloxone and training in its use so that they can respond to opioid overdose in an emergency. Target 3.5 of UN Sustainable Development Goal 3 sets out a commitment by governments to strengthen the prevention and treatment of substance abuse. It is crucial that people with opioid dependence and those at risk of opioid overdose have access to prevention, harm reduction, treatment, and care, which are of good quality, affordable, ethical and evidence based.
Pharmacology, the science of drugs, deals with all aspects of drugs in medicine, including their mechanism of action, physical and chemical properties, metabolism, therapeutics, and drug rehab for pregnant women specialized prenatal treatment toxicity. This article focuses on the principles of drug action and includes an overview of the different types of drugs that are used in the treatment and prevention of human diseases. WHO has been convening the ECDD as a scientific advisory body for over 70 years with the mission to protect populations from harmful substances and to ensure that psychoactive substances are available where needed for medical and scientific purposes. The ECDD conducts scientific reviews at the request of the UN Commission on Narcotic Drugs and is the only treaty-mandated body to provide health recommendations to the Commission to inform decisions in drug policy. The BPPL 2024 also emphasizes the need for a comprehensive public health approach to addressing AMR, including universal access to quality and affordable measures for prevention, diagnosis and appropriate treatment of infections, as outlined in WHO’s People-centred approach to addressing AMR and core package of AMR interventions. Since then there have been incredible advances in drugs for a wide range of health concerns including disease, mental health and other conditions.
A new report from the World Health Organization (WHO) highlights that 2.6 million deaths per year were attributable to alcohol consumption, accounting for 4.7% of all deaths, and 0.6 million deaths to psychoactive drug use. WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers. WHO drug information provides an overview of topics of current relevance relating to drug development and regulation.
WHO recommends that essential medicines, including those that are controlled, be available to all patients at all times at a price that the individual… Boarding is a considerable issue for Medicaid-enrolled youths seeking mental health care in emergency departments (EDs), according to a research letter… Joint UNESCO, UNODC and WHO publication on education sector responses to substance use in 2017 UNESCO (the United Nations Educational, Scientific and Cultural… The publication was invited by resolution 58/5 of the Commission on Narcotic Drugs entitled “Supporting the collaboration of public health and justice…
These pathogens require increased attention, especially in vulnerable populations including paediatric and elderly populations, particularly in resource-limited settings. High priority pathogens, such as Salmonella and Shigella, are of particularly high burden in low- and middle-income countries, along with Pseudomonas aeruginosa and Staphylococcus aureus, which pose significant challenges in healthcare settings. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to medicines, making people sicker and increasing the risk of disease spread, illness and deaths. The updated BPPL incorporates new evidence and expert insights to guide research and development (R&D) for new antibiotics and promote international coordination to foster innovation. Most of the 145 countries that reported data did not have a specific budget line or data on governmental expenditures for treatment of substance use disorders.
FRIDAY, Aug. 15, 2025 — Nearly half of U.S. adults should receive earlier treatment for high blood pressure, including lifestyle changes and medications,… WEDNESDAY, Aug. 20, 2025 — For the first time in 30 years, the American Academy of Pediatrics (AAP) has issued vaccine recommendations that differ… This second review of the world medicines situation (first published in 1988 as The WorldDrug Situation) presents the available evidence on global production,… The Guideline Development Group (GDG) is composed of members from all WHO regions, serving in their individual capacities rather than as representatives of affiliated organizations. GDG members were selected by WHO technical staff based on their technical expertise, their role as end-users (e.g., programme managers and healthcare providers), and their representation of affected communities.
In the third type of mechanism, which is peculiar to steroid hormones and related drugs, the steroid binds to a receptor that consists primarily of nuclear proteins. Because this interaction occurs inside the cell, agonists for this receptor must be able to cross the cell membrane. The drug-receptor complex acts on specific regions of the genetic material deoxyribonucleic acid (DNA) in the cell nucleus, resulting in an increased rate of synthesis for some proteins and a decreased rate for others. Steroids generally act much more slowly (hours to days) than agents that act by either of the two other mechanisms. The BPPL 2024 saw the removal of five pathogen-antibiotic combinations that were included in BPPL 2017, and the addition of four new combinations. The fact that third-generation cephalosporin-resistant Enterobacterales are listed as a standalone item within the critical priority category emphasizes their burden and need for targeted interventions, especially in low- and middle-income countries.
